Virginia Retirement Systems’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
Virginia Retirement Systems's STOK Position: Q3 2026 in Review
Virginia Retirement Systems sold out of Stoke Therapeutics (STOK) in Q3 2026, closing a stake of 13,550 shares — an estimated $443K sold.
Virginia Retirement Systems first reported a position in STOK in Q1 2022 and held it in 9 quarters. The position peaked at $443K in Q2 2026. 184 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- Virginia Retirement Systems reported no remaining Stoke Therapeutics position as of Q3 2026 after selling out during the quarter.
- Virginia Retirement Systems sold 13,550 Stoke Therapeutics shares in Q3 2026, an estimated $443K.
- Virginia Retirement Systems first reported a position in Stoke Therapeutics in Q1 2022 and held it in 9 quarters.
- Virginia Retirement Systems's Stoke Therapeutics position peaked at $443K in Q2 2026.
- 184 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.